🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to evaluate the efficacy and safety of elacestrant, in partic...
Status
Recruiting
Location
Dana Farber Cancer Institute
Start Date
2026-03-25
Trial ID
NCT07467772
Treatments Being Tested
This study is a window of opportunity clinical trial to evaluate the effica...
Status
Completed
Location
Hopital Europeen Georges Pompidou
Start Date
2023-07-20
Trial ID
NCT05659563
Treatments Being Tested
This is a first-in-human, open-label, Phase 1 study evaluating BBI-940, an ...
Status
Terminated
Location
The START Center for Cancer Research
Start Date
2026-02-25
Trial ID
NCT07408089
Treatments Being Tested
The purpose of this study is to visualize and quantify ER-binding sites dur...
Status
Completed
Location
Institut Jules Bordet
Start Date
2016-04-01
Trial ID
NCT02650817
Treatments Being Tested
This is a Phase III open-label study to assess if camizestrant improves out...
Status
Active Not Recruiting
Location
Research Site
Start Date
2023-10-05
Trial ID
NCT05952557
Treatments Being Tested
Trial design: Phase II, prospective, multi-center, randomized, open label,...
Status
Recruiting
Location
Vinzenz Von Paul Kliniken gGmbH - Marienhospital
Start Date
2024-12-13
Trial ID
NCT06201234
Treatments Being Tested
The goal of this research study is to compare a combination of two drugs, c...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2026-01-16
Trial ID
NCT07222215
Treatments Being Tested
This study is a randomized, open-label, multicentric, phase III trial condu...
Status
Completed
Location
Centre Hospitalier Universitaire
Start Date
2017-03-22
Trial ID
NCT03079011
Treatments Being Tested
This is a single-site study. One purpose of this trial is to extend the saf...
Status
Completed
Location
NYU Langone Health
Start Date
2023-11-13
Trial ID
NCT06000501
Treatments Being Tested
A study to investigate camizestrant in combination with atirmociclib in par...
Status
Recruiting
Location
Research Site
Start Date
2026-05-06
Trial ID
NCT07427394
Treatments Being Tested